Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical Orthopaedics and Related Research®
Published in: Clinical Orthopaedics and Related Research® 12/2010

01-12-2010 | Symposium: Papers Presented at the 2009 Closed Meeting of the International Hip Society

What is the Midterm Survivorship and Function After Hip Resurfacing?

Authors: Luthfur Rahman, MRCS, Sarah K. Muirhead-Allwood, FRCS, Muhannad Alkinj, MBBS

Published in: Clinical Orthopaedics and Related Research® | Issue 12/2010

Login to get access

Abstract

Background

Hip resurfacing arthroplasty is a common procedure that improves functional scores and has a reported survivorship between 95% and 98% at 5 years. However, most studies are reported from the pioneering rather than independent centers or have relatively small patient numbers or less than five years followup. Various factors have been implicated in early failure.

Questions/purposes

Our purposes were to determine: (1) the midterm survival of the BHR; (2) the function in patients treated with hip resurfacing; and (3) whether age, gender, BMI, or size of components related to failure.

Methods

We reviewed the first 302 patients (329 hips) on whom we performed resurfacing arthroplasty. We assessed the survivorship, change in functional hip scores (HHS, OHS, WOMAC, UCLA), and analyzed potential risk factors (age, gender, BMI, component size) for failure. The mean age at the time of surgery was 56.0 years (range, 28.2–75.5 years). The minimum followup was 5 years (mean, 6.6 years; range, 5–9.2 years).

Results

Kaplan-Meier analysis showed survival of 96.5% (95% CI, 94.7–98.4) at 9 years taking revision for any cause as the endpoint. All functional hip scores (HHS, OHS, WOMAC, UCLA) improved. Survivorship was higher in men compared with women. The component sizes and body mass index were smaller in the revised group compared with the nonrevised group.

Conclusions

Medium-term survivorship and functional scores of hip resurfacing are comparable to those from the pioneering center. Hip resurfacing remains a good alternative to THA, particularly in the younger male population with relatively large femoral head sizes.

Level of Evidence

Level IV, therapeutic study. See the Guidelines for Authors for a complete description of levels of evidence.
Literature
1.
Amstutz HC, Ball ST, Le Duff MJ, Dorey FJ. Resurfacing THA for patients younger than 50 year: results of 2 to 9 year followup. Clin Orthop Relat Res. 2007;460:159–164.PubMed
2.
Amstutz HC, Beaule PE, Dorey FJ, Le Duff MJ, Campbell PA, Gruen TA. Metal-on-metal hybrid surface arthroplasty: two to six-year follow-up study. J Bone Joint Surg Am. 2004;86:28–39.PubMed
3.
4.
Back DL, Dalziel R, Young D, Shimmin A. Early results of primary Birmingham hip resurfacings: an independent prospective study of the first 230 hips. J Bone Joint Surg Br. 2005;87:324–329.CrossRefPubMed
5.
Beaulé PE, Dorey FJ, LeDuff M, Gruen T, Amstutz HC. Risk factors affecting outcome of metal-on-metal surface arthroplasty of the hip. Clin Orthop Relat Res. 2004;418:87–93.CrossRefPubMed
6.
Bellamy N, Buchanan W, Goldsmith C, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol. 1988;15:1833–1840.PubMed
7.
Bizot P, Banallec L, Sedel L, Nizard R. Alumina-on-alumina total hip prostheses in patients 40 years of age or younger. Clin Orthop Relat Res. 2000;379:68–76.CrossRefPubMed
8.
Buergi ML, Walter WL. Hip resurfacing arthroplasty: the Australian experience. J Arthroplasty. 2007;22:61–65.CrossRefPubMed
9.
Burroughs BR, Hallstrom B, Golladay GJ, Hoeffel D, Harris WH. Range of motion and stability in total hip arthroplasty with 28-, 32-, 38-, and 44-mm femoral head sizes. J Arthroplasty. 2005;20:11–19.CrossRefPubMed
10.
Crowe JF, Mani VJ, Ranawat CS. Total hip replacement in congenital dislocation and dysplasia of the hip. J Bone Joint Surg Am. 1979;61:15–23.PubMed
11.
Daniel J, Pynsent PB, McMinn DJ. Metal-on-metal resurfacing of the hip in patients under the age of 55 years with osteoarthritis. J Bone Joint Surg Br. 2004;86:177–184.CrossRefPubMed
12.
Daniel J, Ziaee H, McMinn DJW. Acetabular bone conservation. In: McMinn D, ed. Modern Hip Resurfacing. London: Springer-Verlag; 2009:129–130.
13.
Dawson J, Fitzpatrick R, Carr A, Murray D. Questionnaire on the perceptions of patients about total hip replacement. J Bone Joint Surg Br. 1996;78:185–190.PubMed
14.
De Haan R, Pattyn C, Gill HS, Murray DW, Campbell PA, De Smet K. Correlation between inclination of the acetabular component and metal ion levels in metal-on-metal hip resurfacing replacement. J Bone Joint Surg Br. 2008;90:1291–1297.CrossRefPubMed
15.
Dorr LD, Kane TJ III, Conaty JP. Long-term results of cemented total hip arthroplasty in patients 45 years old or younger: a 16-year follow-up study. J Arthroplasty. 1994;9:453–456.CrossRefPubMed
16.
Girard J, Lavigne M, Vendittoli PA, Roy AG. Biomechanical reconstruction of the hip: a randomised study comparing total hip resurfacing and total hip arthroplasty. J Bone Joint Surg Br. 2006;88:721–726.PubMed
17.
Grigoris P, Roberts P, Panousis K, Bosch H. The evolution of hip resurfacing arthroplasty. Orthop Clin North Am. 2005;36:125–134, vii.
18.
Hallab N. Metal sensitivity in patients with orthopedic implants. J Clin Rheumatol. 2001;7:215–218.CrossRefPubMed
19.
Harris WH. Traumatic arthritis of the hip after dislocation and acetabular fractures: treatment by mold arthroplasty: an end-result study using a new method of result evaluation. J Bone Joint Surg Am. 1969;51:737–755.PubMed
20.
Hart AJ, Buddhdev P, Winship P, Faria N, Powell JJ, Skinner JA. Cup inclination angle of greater than 50 degrees increases whole blood concentrations of cobalt and chromium ions after metal-on-metal hip resurfacing. Hip Int. 2008;18:212–219.PubMed
21.
Hart AJ, Skinner JA, Winship P, Faria N, Kulinskaya E, Webster D, Muirhead-Allwood S, Aldam CH, Anwar H, Powell JJ. Circulating levels of cobalt and chromium from metal-on-metal hip replacement are associated with CD8+ T-cell lymphopenia. J Bone Joint Surg Br. 2009;91:835–842.CrossRefPubMed
22.
Heilpern GN, Shah NN, Fordyce MJ. Birmingham hip resurfacing arthroplasty: a series of 110 consecutive hips with a minimum five-year clinical and radiological follow-up. J Bone Joint Surg Br. 2008;90:1137–1142.CrossRefPubMed
23.
Howie DW, McCalden RW, Nawana NS, Costi K, Pearcy MJ, Subramanian C. The long-term wear of retrieved McKee-Farrar metal-on-metal total hip prostheses. J Arthroplasty. 2005;20:350–357.CrossRefPubMed
24.
Joshi AB, Porter ML, Trail IA, Hunt LP, Murphy JC, Hardinge K. Long-term results of Charnley low-friction arthroplasty in young patients. J Bone Joint Surg Br. 1993;75:616–623.PubMed
25.
Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457–481.CrossRef
26.
Khan M, Kuiper JH, Edwards D, Robinson E, Richardson JB. Birmingham hip arthroplasty: five to eight years of prospective multicenter results. J Arthroplasty. 2009;24:1044–1050.CrossRefPubMed
27.
Killampalli VV, Kundra RK, Chaudhry F, Chowdhry M, Fisher NE, Reading AD. Resurfacing and uncemented arthroplasty for young hip arthritis: functional outcomes at 5 years. Hip Int. 2009;19:234–238.PubMed
28.
Kobayashi S, Eftekhar NS, Terayama K, Joshi RP. Comparative study of total hip arthroplasty between younger and older patients. Clin Orthop Relat Res. 1997;339:140–151.CrossRefPubMed
29.
Le Duff MJ, Amstutz HC, Dorey FJ. Metal-on-metal hip resurfacing for obese patients. J Bone Joint Surg Am. 2007;89:2705–2711.CrossRefPubMed
30.
Leslie I, Williams S, Brown C, Isaac G, Jin Z, Ingham E, Fisher J. Effect of bearing size on the long-term wear, wear debris, and ion levels of large diameter metal-on-metal hip replacements—an in vitro study. J Biomed Mater Res B Appl Biomater. 2008;87:163–172.PubMed
31.
Lilikakis AK, Vowler SL, Villar RN. Hydroxyapatite-coated femoral implant in metal-on-metal resurfacing hip arthroplasty: minimum of two years follow-up. Orthop Clin North Am. 2005;36:215–222, ix.
32.
MacDonald SJ. Metal-on-metal total hip arthroplasty: the concerns. Clin Orthop Relat Res. 2004;429:86–93.CrossRefPubMed
33.
Madhu TS, Akula MR, Raman RN, Sharma HK, Johnson VG. The Birmingham Hip Resurfacing prosthesis an independent single surgeon’s experience at 7-year follow-up. J Arthroplasty. 2010 Jan 5. [Epub ahead of print]
34.
Mäkelä KT, Eskelinen A, Pulkkinen P, Paavolainen P, Remes V. Total hip arthroplasty for primary osteoarthritis in patients fifty-five years of age or older. An analysis of the Finnish arthroplasty registry. J Bone Joint Surg Am. 2008;90:2160–2170.CrossRefPubMed
35.
Marker DR, Strimbu K, McGrath MS, Zywiel MG, Mont MA. Resurfacing versus conventional total hip arthroplasty—review of comparative clinical and basic science studies. Bull NYU Hosp Jt Dis. 2009;67:120–127.PubMed
36.
McKellop H, Park SH, Chiesa R, Doorn P, Lu B, Normand P, Grigoris P, Amstutz H. In vivo wear of three types of metal on metal hip prostheses during two decades of use. Clin Orthop Relat Res. 1996;329(Suppl):S128–S140.CrossRefPubMed
37.
McMinn DJW. Acetabular preparation and insertion of the standard Birmingham Hip Resurfacing cup. In: McMinn D, ed. Modern Hip Resurfacing. London, England: Springer-Verlag; 2009:223–236.
38.
Mont MA, Ragland PS, Marker D. Resurfacing hip arthroplasty: comparison of a minimally invasive versus standard approach. Clin Orthop Relat Res. 2005;441:125–131.CrossRefPubMed
39.
Mont MA, Seyler TM, Marker DR, Marulanda GA, Delanois RE. Use of metal-on-metal total hip resurfacing for the treatment of osteonecrosis of the femoral head. J Bone Joint Surg Am. 2006;88(Suppl 3):90–97.CrossRefPubMed
40.
41.
42.
Nishii T, Sugano N, Miki H, Takao M, Koyama T, Yoshikawa H. Five-year results of metal-on-metal resurfacing arthroplasty in Asian patients. J Arthroplasty. 2007;22:176–183.CrossRefPubMed
43.
Nunley RM, Della Valle CJ, Barrack RL. Is patient selection important for hip resurfacing? Clin Orthop Relat Res. 2009;467:56–65.CrossRefPubMed
44.
Shimmin AJ, Back D. Femoral neck fractures following Birmingham Hip Resurfacing. J Bone Joint Surg Br. 2005;87:463.CrossRefPubMed
45.
Silva M, Lee KH, Heisel C, Dela Rosa MA, Schmalzried TP. The biomechanical results of total hip resurfacing arthroplasty. J Bone Joint Surg Am. 2004;86:40–46.PubMed
46.
Steffen RT, Foguet PR, Krikler SJ, Gundle R, Beard DJ, Murray DW. Femoral neck fractures after hip resurfacing. J Arthroplasty. 2009;24:614–619.CrossRefPubMed
47.
Steffen RT, Pandit HP, Palan J, Beard DJ, Gundle R, McLardy-Smith P, Murray DW, Gill HS. The five-year results of the Birmingham Hip Resurfacing arthroplasty: an independent series. J Bone Joint Surg Br. 2008;90:436–441.CrossRefPubMed
48.
Treacy RB, McBryde CW, Pynsent PB. Birmingham hip resurfacing arthroplasty: a minimum follow-up of five years. J Bone Joint Surg Br. 2005;87:167–170.CrossRefPubMed
Metadata
Title
What is the Midterm Survivorship and Function After Hip Resurfacing?
Authors
Luthfur Rahman, MRCS
Sarah K. Muirhead-Allwood, FRCS
Muhannad Alkinj, MBBS
Publication date
01-12-2010
Publisher
Springer-Verlag
Published in
Clinical Orthopaedics and Related Research® / Issue 12/2010
Print ISSN: 0009-921X
Electronic ISSN: 1528-1132
DOI
https://doi.org/10.1007/s11999-010-1438-x

Other articles of this Issue 12/2010

Clinical Orthopaedics and Related Research® 12/2010 Go to the issue

Symposium: Papers Presented at the 2009 Closed Meeting of the International Hip Society

Cemented Total Hip Arthroplasty With Subtrochanteric Osteotomy in Dysplastic Hips

Symposium: Papers Presented at the 2009 Closed Meeting of the International Hip Society

Incidence and Factors Associated with Squeaking in Alumina-on-Alumina THA

Clinical Research

Delayed Foreign-body Reaction to Absorbable Implants in Metacarpal Fracture Treatment

Symposium: Papers Presented at the 2009 Closed Meeting of the International Hip Society

Constrained Liner in Neurologic or Cognitively Impaired Patients Undergoing Primary THA

Clinical Research

Ethnic and Gender Differences in the Functional Disparities after Primary Total Knee Arthroplasty

50 Years Ago in CORR

50 Years Ago in CORR: Acrylic Hip Endoprostheses Dana M. Street MD CORR 1955;6:72–85